Found 85 matching trials
Orelabrutinib Combined With Standard Immunochemotherapy With or Without Autologous Hematopoietic Stem Cell Transplantation (Auto-HSCT) for Newly Diagnosed Diffuse Large B-cell Lymphoma (DLBCL) PHASE2 This study is a prospective, open-label, multicenter study in previously un...
Show More Location
The Affiliated Hospital of Xuzhou Medical University
Learn More & Join Trial
German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003) PHASE4 The study evaluates the efficacy and tolerability of an intensified inducti...
Show More Location
University of Frankfurt, Medical Dept. II
Learn More & Join Trial
Orelabrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma PHASE3 B-cell non-Hodgkin's lymphoma (B-NHL) is the most common type of NHL. Altho...
Show More Location
Shandong Provincial Hospital
Learn More & Join Trial
Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia PHASE2 RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Show More Location
Klinikum der J.W. Goethe Universitaet
Learn More & Join Trial
Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents PHASE3 The trial B-NHL 2013 is a collaborative prospective, multi-national, multi-...
Show More Status
Active Not Recruiting
Location
Univ.Klinik fĂŒr Kinder- und Jugendheilkunde Graz, Klin. Abteilung fĂŒr pĂ€diatrische HĂ€mato-Onkologie
Learn More & Join Trial
Nordic Study in Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma PHASE2 The purpose of the study is to test the efficacy and tolerability of a mult...
Show More Location
Elisa Jacobsen Pulczynski
Learn More & Join Trial
Study of Bortezomib Combined With ACVBP in Peripheral T-cell Lymphoma PHASE2 The purpose of this study is to determine the efficacy and the safety profi...
Show More Location
Groupe d'Etude des Lymphomes de l'Adulte
Learn More & Join Trial
Full-course Immunotherapy Combined With Chemotherapy in Newly Diagnosed B-cell Acute Lymphoblastic Leukemia PHASE2 This is a single-arm, prospective, phase 2 clinical trial evaluating the im...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
Reduced-dose Chemotherapy Followed by Blinatumomab in Induction Therapy of Newly Diagnosed Non-elderly Ph-B-ALL PHASE2 Blinatumomab, a CD3/CD19 bisespecific T-cell conjugative antibody, has show...
Show More Location
The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology
Learn More & Join Trial
ZR2 Followed by Immunochemotherapy in Elderly Patients With Newly-diagnosed DLBCL PHASE2 As the most common subtype of lymphoma, diffuse large B-cell lymphoma (DLBC...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial